Björn Fischler

ORCID: 0000-0001-8824-9991
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pediatric Hepatobiliary Diseases and Treatments
  • Drug Transport and Resistance Mechanisms
  • Neonatal Health and Biochemistry
  • Gallbladder and Bile Duct Disorders
  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Organ Transplantation Techniques and Outcomes
  • Cytomegalovirus and herpesvirus research
  • Liver Diseases and Immunity
  • Congenital Anomalies and Fetal Surgery
  • Hepatitis B Virus Studies
  • Intestinal Malrotation and Obstruction Disorders
  • Metabolism and Genetic Disorders
  • Pharmacological Effects and Toxicity Studies
  • Hepatitis C virus research
  • Childhood Cancer Survivors' Quality of Life
  • Pancreatic function and diabetes
  • Transplantation: Methods and Outcomes
  • Infant Nutrition and Health
  • Renal Transplantation Outcomes and Treatments
  • Clinical Nutrition and Gastroenterology
  • Parvovirus B19 Infection Studies
  • Digestive system and related health
  • Folate and B Vitamins Research
  • Gastrointestinal motility and disorders

Karolinska University Hospital
2015-2024

Karolinska Institutet
2015-2024

ERN RARE-LIVER
2020-2023

ERN GUARD-Heart
2020-2023

Children's Hospital Agia Sophia
2021

National and Kapodistrian University of Athens
2021

Wilhelmina Children's Hospital
2020

Kone (Switzerland)
2012

Stockholm University College of Music Education
2002-2005

Pediatrics and Genetics
2002

Cholestatic jaundice in infancy affects approximately 1 every 2500 term infants and is infrequently recognized by primary providers the setting of physiologic jaundice. always pathologic indicates hepatobiliary dysfunction. Early detection care physician timely referrals to pediatric gastroenterologist/hepatologist are important contributors optimal treatment prognosis. The most common causes cholestatic first months life biliary atresia (25%-40%) followed an expanding list monogenic...

10.1097/mpg.0000000000001334 article EN Journal of Pediatric Gastroenterology and Nutrition 2016-07-16

Hepatocellular carcinoma (HCC) is rare in young children. We attempted to see if immunohistochemical and mutational-analysis studies could demonstrate that deficiency of the canalicular bile acid transporter salt export pump (BSEP) mutation ABCB11 , encoding BSEP, underlay progressive familial intrahepatic cholestasis (PFIC)—or “neonatal hepatitis” suggesting PFIC—that was associated with HCC studied 11 cases pediatric setting PFIC or PFIC. Archival liver were retrieved immunostained for...

10.1002/hep.21287 article EN Hepatology 2006-07-26

Progressive familial intrahepatic cholestasis (PFIC) is a group of inherited paediatric liver diseases resulting from mutations in genes that impact bile secretion. We aimed to evaluate the effects odevixibat, an ileal acid transporter inhibitor, versus placebo children with PFIC.Patients eligible for this 24-week, randomised, double-blind, completed, phase 3 study were outpatients diagnosed PFIC1 or PFIC2 who had pruritus and elevated serum acids at screening. Patients randomly assigned...

10.1016/s2468-1253(22)00093-0 article EN cc-by ˜The œLancet. Gastroenterology & hepatology 2022-07-01

Background: In addition to earlier reports on the association between viral infections and intrahepatic neonatal cholestasis, in recent studies, investigators have suggested a similar link extrahepatic biliary atresia. Methods: Fifty-nine cholestatic infants (mean age 8 weeks) were investigated for signs of infection with large spectrum viruses. Twenty-one had atresia, 38 cholestasis. The virologic methods included serologic investigation 59 54 mothers, virus isolation from stools (49...

10.1097/00005176-199807000-00010 article EN Journal of Pediatric Gastroenterology and Nutrition 1998-07-01

Clinical hepatocyte transplantation is hampered by low engraftment rates and gradual loss of function resulting in incomplete correction the underlying disease. Preconditioning with partial hepatectomy improves animal studies. Our aim was to study safety efficacy preconditioning clinical transplantation. Two patients Crigler-Najjar syndrome type I underwent liver resection followed A transient increase growth factor seen, suggesting that this procedure provides a regenerative stimulus. Serum...

10.1111/ajt.13487 article EN cc-by-nc-nd American Journal of Transplantation 2015-11-02
Bettina E. Hansen Shannon M. Vandriel Pamela Vig Will Garner Douglas Mogul and 90 more Kathleen M. Loomes David A. Piccoli Elizabeth B. Rand Irena Jankowska Piotr Czubkowski Dorota Gliwicz‐Miedzińska Emmanuel Gonzalès Emmanuel Jacquemin Jérôme Bouligand Lorenzo D’Antiga Emanuele Nicastro Henrik Arnell Björn Fischler Étienne Sokal Tanguy Demaret Susan Siew Michael Stormon Saul J. Karpen René Romero Noelle H. Ebel Jeffrey A. Feinstein Amin J. Roberts Helen Evans Shikha S. Sundaram Alexander Chaidez Winita Hardikar Sahana Shankar Ryan T. Fischer Florence Lacaille Dominique Debray Henry C. Lin M. Kyle Jensen Catalina Jaramillo Palaniswamy Karthikeyan Giuseppe Indolfi Henkjan J. Verkade Catherine Larson‐Nath Rubén E. Quirós‐Tejeira Pamela L. Valentino Maria Rogalidou Antal Dezsöfi James E. Squires Kathleen B. Schwarz Pier Luigi Calvo Jesús Quintero Andréanne N. Zizzo Gabriella Nebbia Pinar Bulut Ermelinda Santos Silva Rima Fawaz Silvia Nastasio Wikrom Karnsakul María Legarda Tamara Cristina Molera Busoms Déirdre Kelly Thomas Damgaard Sandahl Carolina Jiménez‐Rivera Jesús M. Bañales Quais Mujawar Liting Li Huiyu She Jian‐She Wang Kyung Mo Kim Seak Hee Oh María Camila Sanchez Maria Lorena Cavalieri Way Seah Lee Christina Hajinicolaou Chatmanee Lertudomphonwanit Orith Waisbourd‐Zinman Çiğdem Arıkan Seema Alam Elisa de Carvalho Melina U. Melere John Eshun Zerrin Önal Dev M. Desai Sabina Więcek Raquel Borges Pinto Victorien M. Wolters Jennifer García Marisa Beretta Nanda Kerkar Jernej Brecelj Nathalie Rock Eberhard Lurz Niviann Blondet Uzma Shah Richard J. Thompson Binita M. Kamath

Background and Aims: Alagille syndrome (ALGS) is characterized by chronic cholestasis with associated pruritus extrahepatic anomalies. Maralixibat, an ileal bile acid transporter inhibitor, approved pharmacologic therapy for cholestatic in ALGS. Since long-term placebo-controlled studies are not feasible or ethical children rare diseases, a novel approach was taken comparing 6-year outcomes from maralixibat trials aligned harmonized natural history cohort the G lobal AL agille A lliance...

10.1097/hep.0000000000000727 article EN cc-by-nc-nd Hepatology 2023-12-25

Mutations in ATPase phospholipid transporting 8B1 (ATP8B1) can lead to familial intrahepatic cholestasis type 1 (FIC1) deficiency, or progressive 1. The rarity of FIC1 deficiency has largely prevented a detailed analysis its natural history, effects predicted protein truncating mutations (PPTMs), and possible associations serum bile acid (sBA) concentrations surgical biliary diversion (SBD) with long-term outcome. We aimed provide insights by using the largest genetically defined cohort...

10.1002/hep.31787 article EN cc-by-nc-nd Hepatology 2021-03-05

Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD) and a lead indication for liver transplantation (LT) in western world. In this article, we present Consensus Statement on LT practice, developed by dedicated Guidelines' Taskforce European Society Organ Transplantation (ESOT). The overarching goal to provide practical guidance commonly debated topics, including indications timing LT, management bile duct stenosis patients...

10.3389/ti.2023.11729 article EN cc-by Transplant International 2023-09-29

The aim of the study was to evaluate cognitive and emotional development after pediatric liver transplantation. A total 21 patients, aged 4-16.9 yr (median 9.6 yr) were tested 1-9 4.2 pretransplant diagnoses included biliary atresia (eight patients), various metabolic diseases (n = 6), acute failure 3), miscellaneous 4). functions with Wechsler preschool primary scale intelligence (WPPSI)-R or for children (WISC)-III according age. Piers-Harris self-concept evaluation human figure drawings...

10.1034/j.1399-3046.2003.00081.x article EN Pediatric Transplantation 2003-10-01

<h3>AIM</h3> To time the onset of cytomegalovirus (CMV) infection in patients (n=39) with CMV associated neonatal cholestasis by analysing DNA on Guthrie cards sampled at 3 days age. <h3>METHODS</h3> was diagnosed serology/urine isolation or detection (polymerase chain reaction) liver biopsy specimens. In order to dry blood filter paper discs were punched out from stored cards. After phenol–chloroform extraction detected nested polymerase reaction. <h3>RESULTS</h3> All control children (n=8)...

10.1136/fn.80.2.f130 article EN Archives of Disease in Childhood Fetal & Neonatal 1999-03-01

ABSTRACT Objectives: The aim of this study was to examine whether reversion histological fibrosis followed partial external biliary diversion (PEBD) in patients with progressive familial intrahepatic cholestasis (PFIC); the duration cholestatic episodes after PEBD influenced evolution fibrosis; and genotyping helpful predicting outcome PEBD. Patients Methods: Children PFIC who underwent were investigated genetic, biochemical, anthropometric standard methods. Serial liver specimens assessed...

10.1097/mpg.0b013e3181df99d5 article EN Journal of Pediatric Gastroenterology and Nutrition 2010-07-29

To investigate tacrolimus (Tac)-based treatment in juvenile autoimmune hepatitis (AIH). Twenty patients (13 girls; age, 8-17 years; median, 13.25 years) with AIH were treated two daily oral doses of Tac. Six them had advanced liver disease and/or cirrhosis.Drug concentrations blood measured regularly, and the target trough levels 2.5-5 ng/mL. The followed up for 1 year. Their clinical, biochemical, immunological histological status was obtained at baseline after year.In three cases, Tac...

10.1111/j.1651-2227.2012.02745.x article EN Acta Paediatrica 2012-05-30

Hepatitis E virus (HEV) is endemic in large parts of the developing world. Waterborne transmission genotypes 1 or 2 commonly causes acute hepatitis, which usually self-limited healthy individuals. In addition, HEV infections also occur outside areas, mostly related to foodborne genotype 3. A growing number publications last decade have reported chronic infection progressing cirrhosis immunosuppressed patients. It has been suggested that may via contaminated blood products. This publication...

10.1097/mpg.0000000000001231 article EN Journal of Pediatric Gastroenterology and Nutrition 2016-04-19
Coming Soon ...